Phreesia, Inc. (NYSE:PHR) Stock Has Consensus Price Target of $14.00

Posted by Geri Gentry on Oct 6th, 2026

Phreesia, Inc. (NYSE:PHR – Get Free Report) has been assigned an average recommendation of “Hold” from the nineteen ratings firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, ten have given a hold rating and eight have given a buy rating to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $14.00.

A number of analysts have weighed in on the company. Royal Bank Of Canada reiterated an “outperform” rating and issued a $19.00 price target on shares of Phreesia in a research report on Thursday, September 3rd. Weiss Ratings cut shares of Phreesia from a “sell (d+)” rating to a “sell (d)” rating in a research note on Friday, September 4th. DA Davidson dropped their price objective on shares of Phreesia from $14.00 to $13.00 and set a “buy” rating for the company in a report on Friday, September 4th. Citigroup reiterated a “market perform” rating on shares of Phreesia in a research note on Friday, September 4th. Finally, Canaccord Genuity Group reissued a “buy” rating and issued a $16.00 target price on shares of Phreesia in a report on Thursday, September 3rd.

View Our Latest Analysis on Phreesia

Insider Transactions at Phreesia

In other Phreesia news, General Counsel Allison C. Hoffman sold 6,662 shares of Phreesia stock in a transaction on Monday, September 21st. The stock was sold at an average price of $10.08, for a total value of $67,152.96. Following the completion of the transaction, the general counsel owned 266,574 shares in the company, valued at approximately $2,687,065.92. The trade was a 2.44% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 5.20% of the company’s stock.

Institutional Trading of Phreesia

Several large investors have recently made changes to their positions in PHR. Pale Fire Capital SE raised its holdings in shares of Phreesia by 3.2% in the second quarter. Pale Fire Capital SE now owns 8,924,329 shares of the company’s stock valued at $91,831,000 after buying an additional 275,000 shares during the last quarter. BlackRock Inc. bought a new stake in Phreesia during the 2nd quarter worth about $72,234,000. Granahan Investment Management LLC increased its position in Phreesia by 73.8% in the 4th quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company’s stock valued at $40,601,000 after acquiring an additional 1,018,987 shares in the last quarter. Bank of America Corp DE increased its position in Phreesia by 142.6% in the 1st quarter. Bank of America Corp DE now owns 1,001,057 shares of the company’s stock valued at $8,389,000 after acquiring an additional 588,444 shares in the last quarter. Finally, Meros Investment Management LP raised its stake in shares of Phreesia by 48.5% in the fourth quarter. Meros Investment Management LP now owns 478,274 shares of the company’s stock worth $8,092,000 after acquiring an additional 156,137 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Phreesia Stock Performance

NYSE PHR opened at $10.38 on Friday. Phreesia has a twelve month low of $7.77 and a twelve month high of $24.25. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.33. The stock has a market cap of $643.99 million, a P/E ratio of 61.03 and a beta of 0.84. The company’s 50-day simple moving average is $11.08 and its 200 day simple moving average is $10.22.

Phreesia (NYSE:PHR – Get Free Report) last announced its quarterly earnings results on Wednesday, September 2nd. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.06). Phreesia had a return on equity of 5.22% and a net margin of 2.06%.The business had revenue of $129.46 million for the quarter, compared to the consensus estimate of $129.06 million. During the same quarter in the prior year, the business earned $0.01 EPS. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. As a group, research analysts forecast that Phreesia will post 0.33 earnings per share for the current fiscal year.

About Phreesia

(Get Free Report)

Phreesia, Inc is a healthcare technology company that provides software and services designed to simplify and automate the patient intake process. Its platform helps healthcare organizations manage registration, consent forms, clinical questionnaires, insurance and demographic information, payments, and other administrative tasks through digital tools.

The company’s offerings are used by medical practices, health systems, and other healthcare organizations to improve patient engagement and support administrative and revenue-cycle workflows.